Longer-Lasting Botox Rival Nears US Approval
Reloxin's makers claim it lasts longer
By Ambreen Ali,  Newser User
Posted Apr 2, 2009 8:25 AM CDT
Docs can save money by using Reloxin, some say, because it requires a smaller dosage than Botox for the same results.   (AP Photo)
camera-icon View 2 more images

(Newser) – After a 7-year run as the only show in town, Botox could soon face some competition. Awaiting FDA approval, Reloxin—the US version of a French product called Dysport—is being marketed as a quicker and longer-lasting treatment for botulinum toxin fans. But doctors themselves are confused about what differences, if any, exist between the wrinkle-smoothers, the New York Times reports.

Some docs use the drugs for different wrinkles, but see little disparity. Others purport that, with a practiced hand, they need less of Dysport to produce the same results as Botox. With each dose at more than $250, that could be a hefty savings. But Dysport novices, as many US doctors will be, may fumble until they figure out the proper dosages.